TGA approves use of COVID drug remdesivir

Updated July 11 2020 - 12:11am, first published 12:05am
Remdesivir has been provisionally approved in Australia for treatment of severe cases of COVID-19.
Remdesivir has been provisionally approved in Australia for treatment of severe cases of COVID-19.

The Therapeutic Goods Administration has given provisional approval to a drug that can improve the recovery time of the most seriously ill COVID-19 patients.

Get the latest Katoomba news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.